Zomedica Corp. (ZOMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.0454
+0.0014 (3.30%)
Jun 5, 2025, 9:30 AM EDT
Zomedica Revenue
Zomedica had revenue of $6.50M in the quarter ending March 31, 2025, with 3.80% growth. This brings the company's revenue in the last twelve months to $27.52M, up 6.00% year-over-year. In the year 2024, Zomedica had annual revenue of $27.29M with 8.33% growth.
Revenue (ttm)
27.52M
Revenue Growth
+6.00%
P/S Ratio
1.57
Revenue / Employee
181.07K
Employees
152
Market Cap
43.12M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
American Oncology Network | 1.76B |
Zomedica News
- 15 days ago - Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution - Accesswire
- 16 days ago - Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations - Accesswire
- 20 days ago - Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth - Accesswire
- 23 days ago - Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy - Accesswire
- 27 days ago - Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET - Accesswire
- 2 months ago - Zomedica Corp. (ZOMDF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth - Accesswire
- 3 months ago - Zomedica Corp. Announces Transition to OTCQB Venture Market - Accesswire